Bard Associates’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
Other funds holding ZTS
Bard Associates's ZTS Position: Q2 2026 in Review
Bard Associates increased its Zoetis (ZTS) stake by 1.8% in Q2 2026, buying an estimated $1.98K and bringing the position to 1,218 shares worth $87.5K. The position accounts for 0.02% of the portfolio, ranked #164.
Bard Associates first reported a position in ZTS in Q1 2026 and has held it in 2 quarters since. The position peaked at $141K in Q1 2026. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.
- Bard Associates held 1,218 shares of Zoetis worth $87.5K as of Q2 2026.
- Bard Associates bought 21 Zoetis shares in Q2 2026, an estimated $1.98K.
- Zoetis made up 0.02% of Bard Associates's portfolio in Q2 2026, its #164 holding.
- Bard Associates first reported a position in Zoetis in Q1 2026 and has held it in 2 quarters since.
- Bard Associates's Zoetis position peaked at $141K in Q1 2026.
- 1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.
Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.